April 10, 2025 | UTIs Women's Health
The U.S. Food and Drug Administration (FDA) has approved GSK’s new antibiotic, Blujepa (gepotidacin), for the treatment of uncomplicated urinary tract infections (UTIs) in female patients aged 12 years and older. This marks a significant development in addressing UTIs, which are among the most common bacterial infections, especially in women. Uncomplicated UTIs typically occur in […]
September 15, 2024 | Women's Health
A cystocele, often referred to as a “dropped bladder,” is a common condition affecting many women, particularly those who have had multiple pregnancies or are going through menopause. Understanding what a cystocele is, how it impacts urinary function, and the available treatment options can help you manage and improve your quality of life. What Causes […]
September 12, 2024 | Women's Health
What Is a Rectocele? A rectocele, also known as a posterior vaginal wall prolapse, happens when the supportive tissues between the rectum and vagina become weak or damaged. This weakness allows the rectum to push into the vaginal wall, creating a bulge or protrusion. Symptoms and Sensations of Rectocele – Pelvic Pressure: You may feel […]
August 5, 2024 | Bladder UTIs Women's Health
Jardiance (empagliflozin) is a medication commonly prescribed to manage type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream through urine. While Jardiance is effective in controlling blood sugar levels, it can have notable effects on urination in both men […]
July 22, 2024 | Women's Health
Urinary tract infections (UTIs) are a common issue that affects many women at some point in their lives. Whether it’s a one-time acute infection or a recurrent chronic problem, understanding how to manage and prevent UTIs is crucial. At Austin Urology Institute, we are here to provide you with the knowledge and support you need […]
February 19, 2024 | Bladder Women's Health
At our practice at the Austin Urology Institute, we have noticed a recurring pattern among a subset of patients: active adults under 50 experiencing severe urinary issues despite the absence of bacterial infections. This trend is not unique to our practice but reflects broader shifts in healthcare trends over the last decade. According to data […]
May 4, 2023 | Austin Urology Women's Health
May is Women’s Health Month! The team at Austin Urology Institute is thrilled to join urologists nationwide and advocate for women to prioritize their urologic health this month and beyond. The American Urological Association (AUA) designated May as National Women’s Health Month to raise awareness of urologic health issues that are unique to women. Women’s […]
February 21, 2023 | Make/Well Men's Health The/Age Women's Health
Join us in congratulating Austin urologist Dr. Koushik Shaw and our nurse practitioner Alex Hughes on completing the 2023 Austin Half Marathon this past Sunday, February 19. Given our emphasis on preventative care and a healthy lifestyle, it’s no surprise they have taken on such a challenge. Dr. Shaw and Alex are setting an example by […]
January 10, 2023 | Sexual Health (ED, Hormones, & Fertility) Women's Health
What is Addyi? You’ve probably heard of the “little blue pill,” but what about the “little pink pill”? Addyi is the only FDA-approved medication for treating hypoactive sexual desire (HSDD) in women and it’s available at Austin Urology Institute. Hypoactive sexual desire disorder (HSDD) refers to having little or no interest in sex. Addyi (flibanserin) […]
February 1, 2022 | Low Libido Make/Well Women's Health
Addyí for Women’s Sexual Health Addyí is the #1 prescribed treatment for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. Women who have Hypoactive Sexual Desire Disorder (HSDD) have low sexual desire. Addyí is indicated for the treatment of women with acquired generalized HSDD as characterized by low sexual desire. This causes marked distress or interpersonal difficulty and is not due to […]
Virtual Visits Available
We offer both in-clinic and remote telemedicine consultations in Texas.